Product Detail
N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide)
Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) Product Information
N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101418.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide)
CAS No.
-
CAT No.
CS-T-101418
Molecular Formula
C22H24D4N2O4
Molecular Weight
388.49
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide)"
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) is the labeled analogue of N,N'-(Ethane-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) (E890330), an impurity of Lopinavir (L469480), a selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral."
Synonyms
N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide)
Application Notes
"N,N'-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) is the labeled analogue of N,N'-(Ethane-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide) (E890330), an impurity of Lopinavir (L469480), a selective HIV protease inhibitor. An analogue of Ritonavir. Antiviral."
References
"Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998); Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999); Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)"
